-       Report 
- October 2025
-  185 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Report 
- June 2025
-  150 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
          -       Report 
- March 2022
-  376 Pages 
- Global 
   From       €4292EUR$4,799USD£3,776GBP 
          -       Report 
- February 2023
-  90 Pages 
- Global 
   From       €4428EUR$4,950USD£3,895GBP 
           -       Report 
- November 2023
-  171 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- April 2023
-  97 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
               Pharmaceutical Continuous Manufacturing (PCM) is a process of manufacturing pharmaceuticals that involves the continuous production of drug products. It is an alternative to traditional batch manufacturing, which involves the production of drug products in discrete batches. PCM is a more efficient and cost-effective method of production, as it eliminates the need for multiple production steps and reduces the amount of time and resources required for production. PCM also allows for greater control    over the production process, as it allows for the monitoring of the process in real-time. This allows for the detection of any issues that may arise during production, allowing for a more efficient and cost-effective production process.
PCM is becoming increasingly popular in the pharmaceutical manufacturing industry, as it offers a number of advantages over traditional batch manufacturing. Companies in the PCM market include GEA, Glatt, Bosch, and Siemens. Show Less   Read more